ConductScience.org, home

Paper7348564

Correlation of primary breast cancer histopathology and estrogen receptor content.

Fisher ER and 12 others. Breast Cancer Res Treat, 1981. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. Correlation of primary breast cancer histopathology and estrogen receptor content. Papers, record 7348564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7348564

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Correlation of primary breast cancer histopathology and estrogen receptor content.
PubMed
Journal
Breast Cancer Res Treat
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
1.46
iCite
Revised in PubMed
2026-10-10
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fisher ERE R
2Osborne CKC K
3McGuire WLW L
4Redmond CC
5Knight WA 3rdW A
6Fisher BB
7Bannayan GG
8Walder AA
9Gregory EJE J
10Jacobsen AA
11Queen DMD M
12Bennett DED E
13Ford HCH C

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
CarcinomaMajor topic
Receptors, EstrogenMajor topic
Axilla
Humans
Lymphatic Metastasis

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CB 23862NCI NIH HHSUnited StatesN01CB023862PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
188612Relationship of oestrogen-receptor status to survival in breast cancer.Lancet1979https://conductscience.org/library/papers/88612PubMed
27426746Modern approaches to the treatment of breast cancer.Blood1980https://conductscience.org/library/papers/7426746PubMed
31266807Pathologic findings from the national surgical adjuvant breast project. (Protocol no. 4). III. The significance of extranodal extension of axillary metastases.Am J Clin Pathol1976https://conductscience.org/library/papers/1266807PubMed
4173455The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).Cancer1975https://conductscience.org/library/papers/173455PubMed
5184556The surgical implications of estrophile protein estimations in carcinoma of the breast.Surgery1976https://conductscience.org/library/papers/184556PubMed
6213374Pathological findings from the national surgical adjuvant breast project (Protocol No. 4). IV. Significance of tumor necrosis.Hum Pathol1978https://conductscience.org/library/papers/213374PubMed
7922747Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.Cancer Res1977https://conductscience.org/library/papers/922747PubMed
8476575Relationship between proliferative activity and estrogen receptors in breast cancer.Cancer1979https://conductscience.org/library/papers/476575PubMed
9698968Estrogen receptor assay in primary breast cancer and early recurrence of the disease.Cancer Res1978https://conductscience.org/library/papers/698968PubMed
10174420Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). II. The significance of regional node histology other than sinus histiocytosis in invasive mammary cancer.Am J Clin Pathol1976https://conductscience.org/library/papers/174420PubMed
117351016Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer.Cancer1980https://conductscience.org/library/papers/7351016PubMed
12213652Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content.Lab Invest1978https://conductscience.org/library/papers/213652PubMed
13476576Prognostic value of estrogen receptors in primary breast cancer.Cancer1979https://conductscience.org/library/papers/476576PubMed
147397667Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol no. 4). VI. Discriminants for five-year treatment failure.Cancer1980https://conductscience.org/library/papers/7397667PubMed
1586771Oestrogen receptors and prognosis in early breast cancer.Lancet1979https://conductscience.org/library/papers/86771PubMed
16837364Evaluation of estrogen receptor assays in human breast cancer tissue.Cancer Res1977https://conductscience.org/library/papers/837364PubMed
17476705Association between steroid hormone receptor status and disease-free interval in breast cancer.Cancer Treat Rep1979https://conductscience.org/library/papers/476705PubMed
18922670Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.Cancer1977https://conductscience.org/library/papers/922670PubMed
19698969Prognostic value of estrogen receptor determinations in patients with breast cancer.Cancer Res1978https://conductscience.org/library/papers/698969PubMed

Download CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
36381921Relationship of Tubule Formation, Indian File Pattern and Apocrine Change With Estrogen and Progesterone Receptors and HER2 Immunostaining.Cureus2022https://conductscience.org/library/papers/36381921PubMed
32681091Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer.Nat Commun2020https://conductscience.org/library/papers/32681091PubMed
29297310MultiDCoX: Multi-factor analysis of differential co-expression.BMC Bioinformatics2017https://conductscience.org/library/papers/29297310PubMed
28615951Long-Term Cause-Specific Mortality After Surgery for Women With Breast Cancer: A 20-Year Follow-Up Study From Surveillance, Epidemiology, and End Results Cancer Registries.Breast Cancer (Auckl)2017https://conductscience.org/library/papers/28615951PubMed
26516322Correlation of Hormone Receptor Expression with Histologic Parameters in Benign and Malignant Breast Tumors.Iran J Pathol2015https://conductscience.org/library/papers/26516322PubMed
25392796Temporal trend, clinicopathologic and sociodemographic characterization of age at diagnosis of breast cancer among US women diagnosed from 1990 to 2009.Springerplus2014https://conductscience.org/library/papers/25392796PubMed
24693452Racial disparities in survival and age-related outcome in postsurgery breast cancer patients in a new york city community hospital.ISRN Oncol2014https://conductscience.org/library/papers/24693452PubMed
22947396Derailed estrogen signaling and breast cancer: an authentic couple.Endocr Rev2013https://conductscience.org/library/papers/22947396PubMed
15608675FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.Oncogene2005https://conductscience.org/library/papers/15608675PubMed
11478269Clinicopathological value of somatostatin type 2A and estrogen receptor immunoreactivity in human breast carcinoma.Endocr Pathol2001https://conductscience.org/library/papers/11478269PubMed
8389501Relation of elastosis to biochemical and immunohistochemical steroid receptor findings, Ki-67 and epidermal growth factor receptor (EGFR) immunostaining in invasive ductal breast cancer.Virchows Arch A Pathol Anat Histopathol1993https://conductscience.org/library/papers/8389501PubMed
7150780Oestrogen and progesterone receptor content and the distribution of histological grade in breast cancer.Breast Cancer Res Treat1982https://conductscience.org/library/papers/7150780PubMed
3697513Response to endocrine therapy and breast cancer differentiation.Breast Cancer Res Treat1986https://conductscience.org/library/papers/3697513PubMed
3535933Tumor nuclear grade, estrogen receptor, and progesterone receptor: their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer.Breast Cancer Res Treat1986https://conductscience.org/library/papers/3535933PubMed
3167228Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model.Breast Cancer Res Treat1988https://conductscience.org/library/papers/3167228PubMed
3040158Oestrogen receptor activity in intraduct and invasive breast carcinomas.Breast Cancer Res Treat1987https://conductscience.org/library/papers/3040158PubMed
2992647Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients.Breast Cancer Res Treat1985https://conductscience.org/library/papers/2992647PubMed
1498488The relationship of estrogen receptor status to DNA ploidy in breast cancer.Surg Today1992https://conductscience.org/library/papers/1498488PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7348564

GET https://conductscience.org/api/papers/v1/7348564/authors